vs

Side-by-side financial comparison of HARROW, INC. (HROW) and NOODLES & Co (NDLS). Click either name above to swap in a different company.

NOODLES & Co is the larger business by last-quarter revenue ($122.1M vs $89.1M, roughly 1.4× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -7.5%, a 14.9% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -4.1%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $-2.8M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -1.2%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.

HROW vs NDLS — Head-to-Head

Bigger by revenue
NDLS
NDLS
1.4× larger
NDLS
$122.1M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+37.4% gap
HROW
33.3%
-4.1%
NDLS
Higher net margin
HROW
HROW
14.9% more per $
HROW
7.4%
-7.5%
NDLS
More free cash flow
HROW
HROW
$10.9M more FCF
HROW
$8.1M
$-2.8M
NDLS
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
-1.2%
NDLS

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
HROW
HROW
NDLS
NDLS
Revenue
$89.1M
$122.1M
Net Profit
$6.6M
$-9.2M
Gross Margin
79.3%
Operating Margin
17.5%
-5.2%
Net Margin
7.4%
-7.5%
Revenue YoY
33.3%
-4.1%
Net Profit YoY
-2.2%
32.8%
EPS (diluted)
$0.20
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
NDLS
NDLS
Q4 25
$89.1M
Q3 25
$71.6M
$122.1M
Q2 25
$63.7M
$123.8M
Q1 25
$47.8M
Q4 24
$66.8M
$122.8M
Q3 24
$49.3M
$127.4M
Q2 24
$48.9M
$121.4M
Q1 24
$34.6M
$124.3M
Net Profit
HROW
HROW
NDLS
NDLS
Q4 25
$6.6M
Q3 25
$1.0M
$-9.2M
Q2 25
$5.0M
$-9.1M
Q1 25
$-17.8M
Q4 24
$6.8M
$-6.8M
Q3 24
$-4.2M
$-13.6M
Q2 24
$-6.5M
$-6.1M
Q1 24
$-13.6M
$-6.1M
Gross Margin
HROW
HROW
NDLS
NDLS
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Q1 24
69.5%
Operating Margin
HROW
HROW
NDLS
NDLS
Q4 25
17.5%
Q3 25
20.6%
-5.2%
Q2 25
17.9%
-5.2%
Q1 25
-23.5%
Q4 24
19.3%
-3.9%
Q3 24
2.7%
-9.0%
Q2 24
3.1%
-3.4%
Q1 24
-20.0%
-3.7%
Net Margin
HROW
HROW
NDLS
NDLS
Q4 25
7.4%
Q3 25
1.4%
-7.5%
Q2 25
7.8%
-7.3%
Q1 25
-37.2%
Q4 24
10.1%
-5.5%
Q3 24
-8.6%
-10.7%
Q2 24
-13.2%
-5.1%
Q1 24
-39.2%
-4.9%
EPS (diluted)
HROW
HROW
NDLS
NDLS
Q4 25
$0.20
Q3 25
$0.03
$-0.20
Q2 25
$0.13
$-0.20
Q1 25
$-0.50
Q4 24
$0.19
$-0.15
Q3 24
$-0.12
$-0.30
Q2 24
$-0.18
$-0.14
Q1 24
$-0.38
$-1.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
NDLS
NDLS
Cash + ST InvestmentsLiquidity on hand
$72.9M
$4.7M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$-38.9M
Total Assets
$399.5M
$280.6M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
NDLS
NDLS
Q4 25
$72.9M
Q3 25
$74.3M
$4.7M
Q2 25
$53.0M
$1.4M
Q1 25
$66.7M
Q4 24
$47.2M
$3.3M
Q3 24
$72.6M
$1.8M
Q2 24
$71.0M
$1.3M
Q1 24
$76.0M
$3.0M
Total Debt
HROW
HROW
NDLS
NDLS
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
NDLS
NDLS
Q4 25
$52.4M
Q3 25
$47.0M
$-38.9M
Q2 25
$49.7M
$-13.9M
Q1 25
$56.5M
Q4 24
$69.7M
$3.7M
Q3 24
$58.0M
$9.6M
Q2 24
$58.5M
$21.9M
Q1 24
$60.6M
$27.2M
Total Assets
HROW
HROW
NDLS
NDLS
Q4 25
$399.5M
Q3 25
$363.1M
$280.6M
Q2 25
$345.0M
$319.4M
Q1 25
$364.2M
Q4 24
$389.0M
$340.5M
Q3 24
$351.5M
$346.3M
Q2 24
$306.6M
$360.4M
Q1 24
$295.5M
$368.1M
Debt / Equity
HROW
HROW
NDLS
NDLS
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
NDLS
NDLS
Operating Cash FlowLast quarter
$8.4M
$4.3M
Free Cash FlowOCF − Capex
$8.1M
$-2.8M
FCF MarginFCF / Revenue
9.1%
-2.3%
Capex IntensityCapex / Revenue
0.4%
5.8%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$-7.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
NDLS
NDLS
Q4 25
$8.4M
Q3 25
$16.6M
$4.3M
Q2 25
$-803.0K
$4.0M
Q1 25
$19.7M
Q4 24
$-17.8M
$5.8M
Q3 24
$3.0M
$4.7M
Q2 24
$-2.7M
$7.0M
Q1 24
$-4.6M
$164.0K
Free Cash Flow
HROW
HROW
NDLS
NDLS
Q4 25
$8.1M
Q3 25
$16.4M
$-2.8M
Q2 25
$-969.0K
$1.1M
Q1 25
$19.5M
Q4 24
$-18.3M
$-1.3M
Q3 24
$2.3M
$-4.5M
Q2 24
$-3.1M
$-1.6M
Q1 24
$-4.7M
$-15.2M
FCF Margin
HROW
HROW
NDLS
NDLS
Q4 25
9.1%
Q3 25
22.9%
-2.3%
Q2 25
-1.5%
0.9%
Q1 25
40.8%
Q4 24
-27.4%
-1.1%
Q3 24
4.8%
-3.5%
Q2 24
-6.3%
-1.4%
Q1 24
-13.6%
-12.2%
Capex Intensity
HROW
HROW
NDLS
NDLS
Q4 25
0.4%
Q3 25
0.3%
5.8%
Q2 25
0.3%
2.4%
Q1 25
0.4%
Q4 24
0.8%
5.8%
Q3 24
1.2%
7.2%
Q2 24
0.7%
7.1%
Q1 24
0.3%
12.3%
Cash Conversion
HROW
HROW
NDLS
NDLS
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

NDLS
NDLS

Food And Beverage$119.6M98%
Franchise$2.5M2%

Related Comparisons